DYADIC INTERNATIONAL INC Weighted Average Number of Shares Outstanding, Basic and Diluted
DYADIC INTERNATIONAL INC (DYAI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 27.84 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-29
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 28.09M shares, a 2.19% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 28.08M shares, a 2.17% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 27.65M shares, a 0.65% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 27.53M shares, a 0.29% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 27.84M shares, a 1.33% increase from fiscal 2020.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 27.47M shares, a 1.73% increase from fiscal 2019.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 27.00M shares, a 2.42% decline from fiscal 2018.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 27.67M shares, a 4.30% decline from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 28.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 28.08M shares derived: average of 2 quarters · filed 2022-03-29 | 27.94M shares derived: average of 3 quarters · filed 2022-03-29 | 27.84M shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 28.08M shares 10-Q · filed 2021-11-10 | 27.86M shares derived: average of 2 quarters · filed 2021-11-10 | 27.75M shares 10-Q · filed 2021-11-10 | 27.69M shares derived: average of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | 27.65M shares 10-Q · filed 2021-08-12 | 27.59M shares 10-Q · filed 2021-08-12 | 27.55M shares derived: average of 3 quarters · filed 2022-03-29 | 27.54M shares derived: average of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | 27.53M shares 10-Q · filed 2021-05-13 | 27.51M shares derived: average of 2 quarters · filed 2022-03-29 | 27.50M shares derived: average of 3 quarters · filed 2022-03-29 | 27.49M shares derived: average of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | 27.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 27.48M shares derived: average of 2 quarters · filed 2022-03-29 | 27.48M shares derived: average of 3 quarters · filed 2022-03-29 | 27.47M shares 10-K · filed 2022-03-29 |
| 2020-09-30 | 27.48M shares 10-Q · filed 2021-11-10 | 27.47M shares derived: average of 2 quarters · filed 2021-11-10 | 27.47M shares 10-Q · filed 2021-11-10 | 27.42M shares derived: average of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 27.47M shares 10-Q · filed 2021-08-12 | 27.46M shares 10-Q · filed 2021-08-12 | 27.40M shares derived: average of 3 quarters · filed 2021-08-12 | 27.35M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 27.45M shares 10-Q · filed 2021-05-13 | 27.37M shares derived: average of 2 quarters · filed 2021-05-13 | 27.31M shares derived: average of 3 quarters · filed 2021-05-13 | 27.19M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 27.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | 27.23M shares derived: average of 2 quarters · filed 2021-03-30 | 27.10M shares derived: average of 3 quarters · filed 2021-03-30 | 27.00M shares 10-K · filed 2021-03-30 |
| 2019-09-30 | 27.18M shares 10-Q · filed 2020-11-12 | 27.00M shares derived: average of 2 quarters · filed 2020-11-12 | 26.91M shares 10-Q · filed 2020-11-12 | 26.86M shares derived: average of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | 26.83M shares 10-Q · filed 2020-08-13 | 26.77M shares 10-Q · filed 2020-08-13 | 26.75M shares derived: average of 3 quarters · filed 2020-08-13 | 27.00M shares derived: average of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | 26.71M shares 10-Q · filed 2020-05-14 | 26.71M shares derived: average of 2 quarters · filed 2020-05-14 | 27.06M shares derived: average of 3 quarters · filed 2020-05-14 | 27.31M shares derived: average of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | 26.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 27.24M shares derived: average of 2 quarters · filed 2020-03-30 | 27.51M shares derived: average of 3 quarters · filed 2020-03-30 | 27.67M shares 10-K · filed 2020-03-30 |
| 2018-09-30 | 27.77M shares 10-Q · filed 2019-11-13 | 27.92M shares derived: average of 2 quarters · filed 2019-11-13 | 28.00M shares 10-Q · filed 2019-11-13 | |
| 2018-06-30 | 28.06M shares 10-Q · filed 2019-08-13 | 28.11M shares 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | 28.16M shares 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | 28.92M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |